Cachexia is a serious condition marked by involuntary weight loss, muscle wasting, and metabolic changes, often seen in people with advanced chronic illnesses such as cancer and heart failure12. It affects up to 80% of patients with advanced cancer and is directly responsible for about 20% of cancer-related deaths34. Despite adequate nutrition, cachexia cannot be fully reversed by conventional dietary support, making early diagnosis and comprehensive management essential56.
Cachexia Symptoms and Signs
Cachexia is primarily characterized by a marked, involuntary loss of body weight, predominantly due to the wasting of skeletal muscle and fat tissue78. This muscle atrophy is a central feature and significantly reduces quality of life9. Weight loss in cachexia is not simply due to reduced food intake; it persists despite adequate caloric consumption310. Systemic inflammation is a hallmark, often evidenced by elevated acute-phase proteins like C-reactive protein (CRP) and reduced albumin levels1112.
Common symptoms include:
- Severe weight loss, including loss of both fat and muscle mass78
- Fatigue and generalized weakness, impairing daily activities112
- Anorexia (loss of appetite), although not universal10
- Functional impairment, such as reduced muscle strength and endurance112
- Poor quality of life due to physical and psychological effects13
Early stages, sometimes called "pre-cachexia," may not show obvious weight loss but involve systemic inflammation and functional decline14. In adults, weight loss corrected for fluid retention is the prominent clinical feature6.
Causes of Cachexia
Cachexia arises from a complex interaction of factors including tumor-derived substances, host inflammatory responses, metabolic disturbances, and anorexia31516. It is not simply a nutritional deficiency but a systemic metabolic syndrome resistant to increased caloric intake36.
Key mechanisms include:
- Elevated pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ) that promote muscle protein breakdown and inhibit synthesis1517
- Browning of white adipose tissue leading to increased energy expenditure and fat loss18
- Insulin resistance impairing glucose metabolism and muscle maintenance1
- Increased protein turnover with excessive protein degradation exceeding synthesis1
Risk Factors
Cachexia commonly complicates several chronic diseases, including:
- Advanced cancers, especially gastrointestinal and lung cancers, affecting up to 80% of patients with advanced disease419
- Chronic obstructive pulmonary disease (COPD)20
- Chronic kidney disease (CKD)125
- Chronic heart failure (CHF)2120
- Acquired immune deficiency syndrome (AIDS) and other chronic inflammatory conditions2220
Anorexia and reduced food intake often accompany cachexia but are not always present10. Cachexia frequently represents a late-stage complication in these chronic illnesses9.
Diagnosing Cachexia
Diagnosis of cachexia requires careful assessment of weight loss, muscle wasting, and systemic inflammation in the context of an underlying chronic disease5623. The most widely accepted diagnostic criteria include:
- Involuntary weight loss exceeding 5% within 3 to 12 months, or
- Body mass index (BMI) less than 20 kg/m² with weight loss exceeding 2%, or
- Presence of sarcopenia (muscle loss) with weight loss exceeding 2%5624
Muscle wasting is a defining feature and can be assessed by measuring muscle strength, mass, and functional performance7825. Medical imaging techniques such as computed tomography (CT) scans help evaluate muscle and fat tissue changes and monitor disease progression11.
Laboratory markers commonly used to support diagnosis include elevated CRP and low serum albumin, reflecting systemic inflammation1112. A thorough clinical evaluation also considers symptoms like fatigue, anorexia, and functional impairment11210.
Stages of Cachexia
Cachexia progresses through three stages:
- Pre-cachexia: Early metabolic changes with minimal or no weight loss but signs of systemic inflammation and functional decline14
- Cachexia: Significant involuntary weight loss with muscle wasting and metabolic abnormalities56
- Refractory cachexia: Advanced stage with severe weight loss, poor response to treatment, and limited survival514
Staging helps guide prognosis and management strategies14.
““Diagnostic criteria for cachexia are a 5% weight loss in 12 months or a body mass index of less than 20 kg/m2 in the presence of a known chronic disease...”24”
Cachexia Treatment Options
Management of cachexia is multimodal, focusing on symptom relief, improving function, and quality of life213. Because cachexia is a complex metabolic syndrome, no single treatment is fully effective, and therapy targets multiple pathways.
Nutritional Interventions
Nutritional support is a cornerstone of cachexia management but cannot reverse the syndrome alone12526. Early nutritional intervention may slow progression, but benefits decrease in advanced stages26. Optimal nutritional strategies include:
- High-protein, high-calorie diets to support muscle maintenance125
- Frequent small meals to maximize calorie intake27
- Nutritional counseling by dietitians to tailor interventions27
Tube feeding and parenteral nutrition are generally not recommended as they do not improve survival or cachexia outcomes27.
Pharmacological Interventions
Currently, no pharmacologic agent has demonstrated consistent efficacy in reversing cachexia228. Some medications may improve appetite or symptoms:
- Progestins such as megestrol acetate can stimulate appetite and increase body weight but do not prevent muscle wasting22829
- Ghrelin agonists like anamorelin show promise in improving appetite, body weight, and physical status but require further validation229
- Anti-emetics and appetite stimulants may be used palliatively to improve food intake30
Strength and Endurance Activities
Physical exercise, especially resistance training, may help preserve muscle mass and improve physical function311232. Exercise can counteract metabolic disturbances and improve quality of life in patients with cancer cachexia32. However, barriers such as fatigue, weakness, and psychosocial factors often limit participation32.
Structured, supervised exercise programs, including aerobic and resistance training, are recommended when feasible32. Telehealth may improve access to exercise support, though many patients prefer face-to-face interaction32.
Psychosocial Support
“Well, if [telehealth] makes [exercise] much more available, then it's, that's the greatest benefit.”
— Patient with cachexia32
Cachexia imposes a significant psychosocial burden on patients and families, including distress related to body image changes, loss of independence, and end-of-life concerns1333. Psychosocial interventions are important to address anxiety, depression, and caregiver stress13. Supportive care teams can provide counseling, education, and coping strategies to improve emotional well-being13.
Preventing Cachexia
Prevention focuses on early identification and aggressive management of the underlying disease, combined with nutritional optimization and physical activity311226. Early nutritional and exercise interventions may mitigate muscle wasting and functional decline3112. However, in advanced disease, cachexia often progresses despite optimal care23.
Effective treatment of the primary illness remains the best strategy to delay or prevent cachexia development220. Multidisciplinary approaches involving oncologists, nutritionists, physical therapists, and psychosocial support are essential26.
Conditions Linked to Cachexia
Cachexia commonly occurs in the context of several chronic illnesses, including:
- Advanced cancers, particularly gastrointestinal and lung cancers419
- Chronic obstructive pulmonary disease (COPD)20
- Chronic kidney disease (CKD)125
- Chronic heart failure (CHF)2120
- Acquired immune deficiency syndrome (AIDS) and other chronic inflammatory diseases2220
Cachexia is often a terminal complication in these conditions, underscoring the need for early, comprehensive care2320.
Managing Life with Cachexia
Living with cachexia involves coping with physical, emotional, and social challenges. Cachexia frequently overlaps with sarcopenia (age-related muscle loss), frailty, and malnutrition, especially in elderly patients313435. Comorbidities such as pain, difficulty swallowing (dysphagia), and depression contribute to the overall burden1335.
Management strategies include:
- Nutritional support tailored to patient preferences and tolerances27
- Light physical activity to maintain muscle function when possible3112
- Mental health support to address anxiety and depression13
- Palliative care services to optimize symptom control and quality of life27
Psychosocial distress is common and should be addressed proactively to improve patient and caregiver well-being13.
